CAR-T Congress EU and Vein-To-Vein Congress EU
Jan 28 - Jan 30, 2020
Discovery, Translation, Commercialization: Developing CAR-T into viable, accessible therapies
Tackling the manufacturing, scale-up, regulatory and logistical bottlenecks to commercialize cell therapies for the mainstream
Meet Immatics at the combined congresses CAR-T EU and Vein-To-Vein EU in London and discuss cell therapy manufacturing innovations: From streamlining logistics to scaling and automating manufacturing processes and developing robust raw material supply chains to get a viable, accessible therapy.
Tuesday, Jan 28, 9.30am-10.30am
Panel: Process development and preparation for upscaling manufacturing for clinical and commercial manufacturing – what are the considerations right now?
Moderator and Panelist: Ali Mohamed, VP CMC Immatics US
Tuesday, Jan 28, 11.45am-12.30pm
Panel: CMO or In-House: what’s best for your growth plan?
Panelist: Ali Mohamed, VP CMC Immatics US
Wednesday, Jan 29, 2.45-3.15pm
Talk: Cutting Vein to Vein time to 10 days when manufacturing younger cellsChair and Speaker: Ali Mohamed, VP CMC Immatics US
We are looking forward to seeing you there.
Further information on Vein-To-Vein Congress EU Congress here.
Further information on CAR-T Congress EU here